Exogene Company
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.
Connections from
Funding Status:
Seed
Industry:
Biomarkers
Investors Number:
8
Last Funding Date:
2022-04-25
Founded Date:
2019-11-01
Headquarters:
London, England, United Kingdom
Total Funding:
2105637
Last Funding Type:
Seed
Employee Number:
1-10